Without adapting JCA to include assessment of real world data (RWD) and broader benefits, vaccines may be undervalued, ...

Merck (known as MSD outside the US and Canada) has entered into a definitive agreement to acquire Cidara Therapeutics, a ...

Novartis has reported positive top-line results from the phase 3 KALUMA trial evaluating KLU156 (ganaplacide/lumefantrine, or ...

Johnson & Johnson (J&J) has received a positive recommendation from the UK’s National Institute for Health and Care ...

It’s reshaping what awareness, diagnosis and care must look like in the UK and across Europe. New efforts, such as ‘Jess’s ...

PMEA returned on 19 November to the Sheraton Grand in London to recognise excellence within pharmaceutical marketing. The ...

For decades, menopause has been swept under the rug, or into the dark corners of clinicians’ offices, often dismissed as ...

VML Portugal has announced the launch of VML Health, with pharma communications veteran Mariana Marta dos Santos being ...

Discover how pharmaceutical companies are using asynchronous platforms and microlearning to eliminate geographical barriers, ...

The true measure of a medical leader is the courage to act when existing systems fail the patient. This is the professional ...

Biogen and Eisai have announced that the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved an ...

InflaRx – a biopharmaceutical company developing anti-inflammatory therapeutics targeting the complement system – has ...